Amundi’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$511K Sell
21,940
-24,884
-53% -$536K ﹤0.01% 1543
2025
Q4
$936K Buy
46,824
+36,468
+352% +$712K ﹤0.01% 1284
2025
Q3
$180K Buy
+10,356
New +$202K ﹤0.01% 1549
2024
Q2
Sell
-9,207
Closed -$135K 1987
2024
Q1
$135K Buy
9,207
+1,700
+23% +$26.7K ﹤0.01% 1714
2023
Q4
$123K Hold
7,507
﹤0.01% 1730
2023
Q3
$99.9K Sell
7,507
-605
-7% -$7.86K ﹤0.01% 1754
2023
Q2
$103K Sell
8,112
-1,834
-18% -$23K ﹤0.01% 1760
2023
Q1
$116K Buy
9,946
+8,547
+611% +$104K ﹤0.01% 1703
2022
Q4
$18.8K Buy
+1,399
New +$18.4K ﹤0.01% 1806
2022
Q3
Sell
-1,399
Closed -$20K 1873
2022
Q2
$20K Buy
+1,399
New +$22.9K ﹤0.01% 1600
2021
Q3
Sell
-13,946
Closed -$187K 1598
2021
Q2
$187K Buy
+13,946
New +$175K ﹤0.01% 1390

Other funds holding INVA

Amundi's INVA Position: Q1 2026 in Review

Amundi reduced its Innoviva (INVA) stake by 53% in Q1 2026, selling an estimated $536K and leaving 21,940 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #1543.

Amundi first reported a position in INVA in Q2 2021 and has held it in 11 quarters since. The position peaked at $936K in Q4 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Amundi held 21,940 shares of Innoviva worth $511K as of Q1 2026.
  • Amundi sold 24,884 Innoviva shares in Q1 2026, an estimated $536K.
  • Innoviva made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1543 holding.
  • Amundi first reported a position in Innoviva in Q2 2021 and has held it in 11 quarters since.
  • Amundi's Innoviva position peaked at $936K in Q4 2025.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.